Delivery Order SPE2DB22D2206-SPE2DB24FHS94
Award Date 6/12/24
Potential Completion Date 6/13/24
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of HYZAAR 100-12.5 TABLET 30S medication, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $9,635.71 firm fixed-price delivery order contract has a completion date of November 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The $2,275.00 firm-fixed price delivery order is for the supply of HYZAAR 100-25 Tablets (30 count) to support DLA's medical supply requirements. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the main...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,783.97 firm fixed-price delivery order is for the supply of HYZAAR 100-25 tablets, with a period of performance through January 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is a firm fixed price delivery order between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, with a potential value of $1,102.08 and a completion date of February 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,415.58, is a Delivery Order for the procurement of HYZAAR 100-25 Tablets with an ultimate completion date of May 23, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award, with ID SPE2DB20D1004|SPE2DB25FNGTE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,299.69 delivery order contract is for the supply of HYZAAR 50-12.5 TABLET 30S, a medication, and is a Firm Fixed Price contract. The award date is April 30, 2025, with a completion date of May 1, 2025. The contract is not set aside and is an open competition award....
- This federal contract award is for the delivery of Hyzaar 100-25 tablets to the Defense Logistics Agency (DLA). The $7,654.47 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 1, 2022 with a completion date of February 2, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System for Award Management (SAM.gov) as a for-profit organization. The contract does not...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,676.81, is for the supply of HYZAAR 100-12.5 TABLET 30S medication to support military healthcare programs. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB24FC4F1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,270.92 firm fixed-price delivery order covers the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, with a performance period through June 26, 2024. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,881.84, is a Delivery Order for the supply of HYZAAR 100-12.5 TABLET 30S medical products. The contract has a firm fixed price and an ultimate completion date of February 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...